Recent data from the Brigham and Women’s Hospital Rheumatoid Arthritis Sequential Study (BRASS), a prospective observational RA cohort, highlights the improvements in HDL-C efflux capacity with reductions in high sensitivity CRP [152]. Here, CRP is linked to rheumatoid arthritis.